Qube Research & Technologies LTD Insmed Inc Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Insmed Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 489,307 shares of INSM stock, worth $32.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
489,307Holding current value
$32.4 Million% of portfolio
0.05%Shares
4 transactions
Others Institutions Holding INSM
# of Institutions
465Shares Held
182MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$946 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$834 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$696 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$432 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $8.98B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...